Hepatic iron overload: Direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis

Richard Press, Ken Flora, Cindy Gross, John M. Rabkin, Christopher Corless

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Among patients with hepatic iron overload, the distinction between hereditary hemochromatosis (HH), a common yet treatable genetic disease, and other causes of siderosis remains problematic. The recent discovery of a specific homozygous mutation (C282Y) in a novel major histocompatibility complex class I-like gene (named HLA-H or HFE) in 80% to 100% of well- characterized cases of HH suggests that direct DNA-based mutation analysis may help resolve this dilemma. To assess the clinical utility of direct HLA- H mutation analysis in a typical diagnostic setting, we measured genotypic and phenotypic parameters of iron overload in 37 subjects with biopsy-proven hepatic siderosis (2+ or greater) and in 127 healthy control subjects. The prevalence of C282Y homozygotes was significantly greater in the hepatic siderosis group (32%) than in the control group (0%), confirming the association between this homozygous mutation and hepatic iron overload. In the hepatic siderosis group, C282Y homozygotes had significantly higher hepatic iron and ferritin levels, a significantly lower prevalence of hepatitis C virus or alcoholic liver disease, but no significant difference in the saturation of serum transferrin. Of the 20 subjects with a hepatic iron index (HII) in the previously defined 'hemochromatosis range' (>1.9), 9 (45%) were C282Y homozygotes. Of the 11 nonhomozygous subjects with an HII greater than 1.9 (presumed false-positive HIIs), 10 (91%) had hepatic cirrhosis compared with 3 of 9 (33%) homozygotes with an HII greater than 1.9 who had cirrhosis (P

Original languageEnglish (US)
Pages (from-to)577-584
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume109
Issue number5
StatePublished - 1998

Fingerprint

Iron Overload
Hemochromatosis
Iron
Siderosis
Mutation
Liver
Homozygote
MHC Class I Genes
Alcoholic Liver Diseases
Inborn Genetic Diseases
Transferrin
Ferritins
Major Histocompatibility Complex
Hepacivirus
Liver Cirrhosis
Healthy Volunteers
Fibrosis
Biopsy
Control Groups
DNA

Keywords

  • Diagnosis
  • Genetics
  • Hemochromatosis
  • Hemosiderosis
  • HFE
  • HLA antigens
  • Iron overload
  • Liver cirrhosis
  • Mutation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{15240d2efb99442db7e39eb52db54254,
title = "Hepatic iron overload: Direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis",
abstract = "Among patients with hepatic iron overload, the distinction between hereditary hemochromatosis (HH), a common yet treatable genetic disease, and other causes of siderosis remains problematic. The recent discovery of a specific homozygous mutation (C282Y) in a novel major histocompatibility complex class I-like gene (named HLA-H or HFE) in 80{\%} to 100{\%} of well- characterized cases of HH suggests that direct DNA-based mutation analysis may help resolve this dilemma. To assess the clinical utility of direct HLA- H mutation analysis in a typical diagnostic setting, we measured genotypic and phenotypic parameters of iron overload in 37 subjects with biopsy-proven hepatic siderosis (2+ or greater) and in 127 healthy control subjects. The prevalence of C282Y homozygotes was significantly greater in the hepatic siderosis group (32{\%}) than in the control group (0{\%}), confirming the association between this homozygous mutation and hepatic iron overload. In the hepatic siderosis group, C282Y homozygotes had significantly higher hepatic iron and ferritin levels, a significantly lower prevalence of hepatitis C virus or alcoholic liver disease, but no significant difference in the saturation of serum transferrin. Of the 20 subjects with a hepatic iron index (HII) in the previously defined 'hemochromatosis range' (>1.9), 9 (45{\%}) were C282Y homozygotes. Of the 11 nonhomozygous subjects with an HII greater than 1.9 (presumed false-positive HIIs), 10 (91{\%}) had hepatic cirrhosis compared with 3 of 9 (33{\%}) homozygotes with an HII greater than 1.9 who had cirrhosis (P",
keywords = "Diagnosis, Genetics, Hemochromatosis, Hemosiderosis, HFE, HLA antigens, Iron overload, Liver cirrhosis, Mutation",
author = "Richard Press and Ken Flora and Cindy Gross and Rabkin, {John M.} and Christopher Corless",
year = "1998",
language = "English (US)",
volume = "109",
pages = "577--584",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

TY - JOUR

T1 - Hepatic iron overload

T2 - Direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis

AU - Press, Richard

AU - Flora, Ken

AU - Gross, Cindy

AU - Rabkin, John M.

AU - Corless, Christopher

PY - 1998

Y1 - 1998

N2 - Among patients with hepatic iron overload, the distinction between hereditary hemochromatosis (HH), a common yet treatable genetic disease, and other causes of siderosis remains problematic. The recent discovery of a specific homozygous mutation (C282Y) in a novel major histocompatibility complex class I-like gene (named HLA-H or HFE) in 80% to 100% of well- characterized cases of HH suggests that direct DNA-based mutation analysis may help resolve this dilemma. To assess the clinical utility of direct HLA- H mutation analysis in a typical diagnostic setting, we measured genotypic and phenotypic parameters of iron overload in 37 subjects with biopsy-proven hepatic siderosis (2+ or greater) and in 127 healthy control subjects. The prevalence of C282Y homozygotes was significantly greater in the hepatic siderosis group (32%) than in the control group (0%), confirming the association between this homozygous mutation and hepatic iron overload. In the hepatic siderosis group, C282Y homozygotes had significantly higher hepatic iron and ferritin levels, a significantly lower prevalence of hepatitis C virus or alcoholic liver disease, but no significant difference in the saturation of serum transferrin. Of the 20 subjects with a hepatic iron index (HII) in the previously defined 'hemochromatosis range' (>1.9), 9 (45%) were C282Y homozygotes. Of the 11 nonhomozygous subjects with an HII greater than 1.9 (presumed false-positive HIIs), 10 (91%) had hepatic cirrhosis compared with 3 of 9 (33%) homozygotes with an HII greater than 1.9 who had cirrhosis (P

AB - Among patients with hepatic iron overload, the distinction between hereditary hemochromatosis (HH), a common yet treatable genetic disease, and other causes of siderosis remains problematic. The recent discovery of a specific homozygous mutation (C282Y) in a novel major histocompatibility complex class I-like gene (named HLA-H or HFE) in 80% to 100% of well- characterized cases of HH suggests that direct DNA-based mutation analysis may help resolve this dilemma. To assess the clinical utility of direct HLA- H mutation analysis in a typical diagnostic setting, we measured genotypic and phenotypic parameters of iron overload in 37 subjects with biopsy-proven hepatic siderosis (2+ or greater) and in 127 healthy control subjects. The prevalence of C282Y homozygotes was significantly greater in the hepatic siderosis group (32%) than in the control group (0%), confirming the association between this homozygous mutation and hepatic iron overload. In the hepatic siderosis group, C282Y homozygotes had significantly higher hepatic iron and ferritin levels, a significantly lower prevalence of hepatitis C virus or alcoholic liver disease, but no significant difference in the saturation of serum transferrin. Of the 20 subjects with a hepatic iron index (HII) in the previously defined 'hemochromatosis range' (>1.9), 9 (45%) were C282Y homozygotes. Of the 11 nonhomozygous subjects with an HII greater than 1.9 (presumed false-positive HIIs), 10 (91%) had hepatic cirrhosis compared with 3 of 9 (33%) homozygotes with an HII greater than 1.9 who had cirrhosis (P

KW - Diagnosis

KW - Genetics

KW - Hemochromatosis

KW - Hemosiderosis

KW - HFE

KW - HLA antigens

KW - Iron overload

KW - Liver cirrhosis

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=0031919860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031919860&partnerID=8YFLogxK

M3 - Article

C2 - 9576576

AN - SCOPUS:0031919860

VL - 109

SP - 577

EP - 584

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -